In vitro and in vivo effects of Khaya grandifoliola C. DC. (Meliaceae) leaf on erectile dysfunction in male rats
Abstract
Background: Khaya grandifoliola C. DC. (Meliaceae) is exploited as a popular antimalarial herbal medicine in Nigeria, externally in treating skin diseases, and to enhance libido.Objectives: This study evaluates the aphrodisiac potential of K. grandifoliola leaf in male Wistar rats. Materials and methods: Aphrodisiac property was determined by oral administration of graded doses: 100, 250 and 1000 mg/kg of crude methanol (MeOH) extract of K. grandifoliola leaf, and 100 and 200 mg/kg each of aqueous (AQ) and dichloromethane (DCM) fractions to male rats using standard procedure. Sildenafil citrate and distilled water served as positive and negative controls, respectively. Sexual behavioural parameters like mounting, intromission and ejaculatory frequencies and latencies were recorded on day 7. Anti-lipid peroxidation effect and serum testosterone concentrations were also monitored.
Results: From the sexual behavioural study, MeOH extract of the leaf was active and significantly increased mount and ejaculatory frequencies, and decreased mount and ejaculatory latencies in a dose dependent manner, but had no effect on intromission latency and intromission frequency. Both AQ and DCM fractions were more active than extract, comparable to Sildenafil citrate, but DCM fraction was comparatively more active. Testosterone concentrations were also increased dose-dependently by all tested agents, but DCM fraction was the most active and comparable to Sildenafil citrate. Only DCM fraction…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.